SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Schedule 13G

(Rule 13d-102)

Information to be Included in Statements Filed Pursuant to Rules § 240.13d-1(b), (c)

and (d) and Amendments Thereto Filed Pursuant To Rule § 240.13d-2.

Under the Securities Exchange Act of 1934

(Amendment No. 2) *

 

 

Concord Medical Services Holdings Limited

(Name of Issuer)

Ordinary Shares, par value US$0.0001 per share

(Title of Class of Securities)

206277 105¹

(CUSIP Number)

December 31, 2012

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

[Continued on following pages]

 

 

1	This CUSIP number applies to the Issuer’s American Depositary Shares, each representing three Ordinary Shares.

 

 

 

---

SCHEDULE 13G

 

CUSIP No. 206277 105		Page 2 of 8 Pages

 

1		Name of reporting person   China Medical Scientific Holdings Limited (Formerly known as Notable Enterprise Limited)
2		Check the appropriate box if a member of a group (a)  ¨        (b)  ¨
3		SEC use only
4		Citizenship or place of organization       British Virgin Islands
Number of shares beneficially owned by each reporting person with				5		Sole voting power       11,145,095
				6		Shared voting power       0
				7		Sole dispositive power       11,145,095
				8		Shared dispositive power       0
9		Aggregate amount beneficially owned by each reporting person       11,145,095
10		Check box if the aggregate amount in Row (9) excludes certain shares    ¨
11		Percent of class represented by amount in Row 9       7.83%
12		Type of reporting person       OO (British Virgin Islands Limited Liability Company)

 

---

SCHEDULE 13G

 

CUSIP No. 206277 105		Page 3 of 8 Pages

 

1		Name of reporting person   Bona Lau
2		Check the appropriate box if a member of a group (a)  ¨        (b)  ¨
3		SEC use only
4		Citizenship or place of organization        New Zealand
Number of shares beneficially owned by each reporting person with				5		Sole voting power        11,145,095
				6		Shared voting power       0
				7		Sole dispositive power       11,145,095
				8		Shared dispositive power       0
9		Aggregate amount beneficially owned by each reporting person       11,145,095
10		Check box if the aggregate amount in Row (9) excludes certain shares    ¨
11		Percent of class represented by amount in Row 9       7.83%
12		Type of reporting person       IN

 

---

 

		SCHEDULE 13G
CUSIP NO. 206277 105				Page 4 of 8 Pages

 

ITEM 1(a).

NAME OF ISSUER:

Concord Medical Services Holdings Limited (the “Issuer”)

 

ITEM 1(b).

ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

18/F, Tower A, Global Trade Center

36 North Third Ring Road East

Dongcheng District, Beijing 100013

The People’s Republic of China

 

ITEM 2(a).

NAME OF PERSON FILING:

China Medical Scientific Holdings Limited

Bona Lau

 

ITEM 2(b).

ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE:

For China Medical Scientific Holdings Limited:

P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands

For Bona Lau:

P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands

 

ITEM 2(c)

CITIZENSHIP:

China Medical Scientific Holdings Limited - British Virgin Islands

Bona Lau - New Zealand

 

ITEM 2(d).

TITLE OF CLASS OF SECURITIES:

Ordinary Shares, par value US$0.0001 per share

 

ITEM 2(e).

CUSIP NUMBER:

206277 105

---

 

		SCHEDULE 13G
CUSIP NO. 206277 105				Page 5 of 8 Pages

 

ITEM 3.

STATEMENT FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b) or (c):

Not applicable

 

ITEM 4.

OWNERSHIP.

The following information with respect to the ownership of the Ordinary Shares of the Issuer by the person filing this statement is provided as of December 31, 2012. The percentage amount is based on 142,353,532 Ordinary Shares outstanding as of December 31, 2012, as derived from the Issuer’s corporate records.

 

										Number of shares as to which the person has:
Reporting Person		Amount beneficially owned:				Percent of class:				Sole power to vote or to direct the vote:				Shared power to vote or to direct the vote:				Sole power to dispose or to direct the disposition of:				Shared power to dispose or to direct the disposition of:
China Medical Scientific Holdings Limited			11,145,095				7.83	%			11,145,095				0				11,145,095				0
Bona Lau			11,145,095				7.83	%			11,145,095				0				11,145,095				0

China Medical Scientific Holdings Limited holds 11,145,095 Ordinary Shares of the Issuer. Bona Lau is the sole shareholder of China Medical Scientific Holdings Limited.

 

ITEM 5.

OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following:    ¨

 

ITEM 6.

OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

Not Applicable.

 

ITEM 7.

IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

Not Applicable.

---

 

		SCHEDULE 13G
CUSIP NO. 206277 105				Page 6 of 8 Pages

 

ITEM 8.

IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

Not Applicable.

 

ITEM 9.

NOTICE OF DISSOLUTION OF GROUP.

Not Applicable.

 

ITEM 10.

CERTIFICATION.

Not Applicable.

---

 

		SCHEDULE 13G
CUSIP NO. 206277 105				Page 7 of 8 Pages

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2013

 

---

 

		SCHEDULE 13G
CUSIP NO. 206277 105				Page 8 of 8 Pages

 

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		Joint Filing Agreement (incorporated by reference to Exhibit 99.1 of the initial Schedule 13G filed with the Securities and Exchange Commission on February 12, 2010)